A carregar...

Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination

The multi-kinase inhibitor sunitinib malate (SUT) has been reported to reduce levels of myeloid suppressor cells and Treg cells in cancer patients, hypothetically diminishing intrinsic impediments for active immunization against tumor-associated antigens in such individuals. The goal of this study w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bose, Anamika, Taylor, Jennifer L., Alber, Sean, Watkins, Simon C., Garcia, Jorge A., Rini, Brian I., Ko, Jennifer S., Cohen, Peter A., Finke, James H., Storkus, Walter J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3110980/
https://ncbi.nlm.nih.gov/pubmed/21170961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.25863
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!